Dr. Sharla Gayle Patterson, MD

Dr. Patterson practices at Encore Urology in Naples, Florida.

Dr. Patterson's NPI, 1760570626, was assigned on October 10, 2006. Dr. Patterson graduated from Texas Tech University Health Sciences Center School of Medicine in 2004. Dr. Patterson holds Florida license ME115033.

Dr. Patterson's primary practice is Encore Urology, at 11181 Health Park Blvd, Naples, FL 34110 in Collier County. The practice phone is (239) 597-4440.

Dr. Patterson's primary practice is Encore Urology in Naples, Florida. Dr. Patterson is also affiliated with NCH Baker Hospital. The medical group on file is Advocate Radiation Oncology. Dmand AI also links Dr. Patterson to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patterson practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Patterson's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Patterson is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Patterson's licenses on file in 4 states: Florida, Mississippi, Alabama and Georgia.

Dmand AI lists breast reconstruction and mastectomy among the conditions Dr. Patterson treats.

CMS data shows 1,263 Medicare services from Dr. Patterson across 15 procedure codes in 2024, for 733 Medicare patients. Medicare paid $179,949 for them.

CMS counts 733 Medicare patients who saw Dr. Patterson in 2024. The largest group is 75 to 84, with 338 patients. 75% of them have high cholesterol, and 70% have cancer. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Patterson's median patient age at 72, with 97% women.

In 2024, Dr. Patterson wrote 408 Medicare Part D claims for 191 patients. 97% of them were for generic drugs. CMS names the drug for 341 of them, across 5 drugs with 11 or more claims each, at $8,687 in total drug cost. In 2023, CMS named 346 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Patterson for performance year 2024, reported individually. Dr. Patterson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 94 procedures of mastectomy by Dr. Patterson, more than 99% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Patterson, published from 2006 to 2013. The most frequent topics are Breast Neoplasms and Carcinoma, Ductal, Breast. Dr. Patterson has published most often in Am Surg. Dr. Patterson's most frequent co-authors are Monica U. Rizzo, MD, Grant W. Carlson, MD and Radha Gopal Iyengar, MD.

Dmand AI links Dr. Patterson to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 101 general payments to Dr. Patterson from 25 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 29% of the total. Medtronic USA, Inc. paid the most, $7,107.

Dmand AI lists 1 award for Dr. Patterson.

Dr. Patterson graduated from Texas Tech University Health Sciences Center School of Medicine in 2004. Dr. Patterson is a member of ACS.

Dr. Patterson is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.